Drug intelligence / Profile preview

Amoxikid

Development stage
Unknown
Lead developer
Kampala Pharmaceutical Industries
Modality
Small Molecules
Administration
Oral
01

Overview

Amoxikid is a branded generic antibiotic manufactured by Kampala Pharmaceutical Industries (KPI) Ltd, a leading pharmaceutical manufacturer based in Uganda. The drug is part of KPI's portfolio of essential medicines and is distributed across the East African region, including Uganda, Kenya, Tanzania, South Sudan, and Rwanda. Based on its name and the manufacturer's focus on pediatric health, Amoxikid is a pediatric formulation of amoxicillin, a semi-synthetic, broad-spectrum beta-lactam antibiotic. It is used to treat various bacterial infections by inhibiting the synthesis of bacterial cell walls. Specifically, it binds to penicillin-binding proteins (PBPs), which prevents the final transpeptidation step of peptidoglycan synthesis, leading to bacterial cell lysis and death.

Brand names
Amoxikid
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Amoxikid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amoxikid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call